Global Antibody Drugs Market Size, Status and Forecast 2019-2025

Published On: May 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 275915

In 2018, the global Antibody Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Antibody Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antibody Drugs development in United States, Europe and China.

The key players covered in this study
Novartis
Amgen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson & Johnson
AbbVie
Eli Lilly
...

Market segment by Type, the product can be split into
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies

Market segment by Application, split into
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antibody Drugs status, future forecast, growth opportunity, key market and key players.
To present the Antibody Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antibody Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Antibody Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Antibody-Drug Conjugates
1.4.4 Polyclonal Antibodies
1.5 Market by Application
1.5.1 Global Antibody Drugs Market Share by Application (2014-2025)
1.5.2 Central Nervous System (CNS) Disorders
1.5.3 Cancers
1.5.4 Autoimmune Disorders
1.5.5 Cardiovascular Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Antibody Drugs Market Size
2.2 Antibody Drugs Growth Trends by Regions
2.2.1 Antibody Drugs Market Size by Regions (2014-2025)
2.2.2 Antibody Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Antibody Drugs Market Size by Manufacturers
3.1.1 Global Antibody Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Antibody Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antibody Drugs Key Players Head office and Area Served
3.3 Key Players Antibody Drugs Product/Solution/Service
3.4 Date of Enter into Antibody Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Antibody Drugs Market Size by Type (2014-2019)
4.2 Global Antibody Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Antibody Drugs Market Size (2014-2019)
5.2 Antibody Drugs Key Players in United States
5.3 United States Antibody Drugs Market Size by Type
5.4 United States Antibody Drugs Market Size by Application

6 Europe
6.1 Europe Antibody Drugs Market Size (2014-2019)
6.2 Antibody Drugs Key Players in Europe
6.3 Europe Antibody Drugs Market Size by Type
6.4 Europe Antibody Drugs Market Size by Application

7 China
7.1 China Antibody Drugs Market Size (2014-2019)
7.2 Antibody Drugs Key Players in China
7.3 China Antibody Drugs Market Size by Type
7.4 China Antibody Drugs Market Size by Application

8 Japan
8.1 Japan Antibody Drugs Market Size (2014-2019)
8.2 Antibody Drugs Key Players in Japan
8.3 Japan Antibody Drugs Market Size by Type
8.4 Japan Antibody Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Antibody Drugs Market Size (2014-2019)
9.2 Antibody Drugs Key Players in Southeast Asia
9.3 Southeast Asia Antibody Drugs Market Size by Type
9.4 Southeast Asia Antibody Drugs Market Size by Application

10 India
10.1 India Antibody Drugs Market Size (2014-2019)
10.2 Antibody Drugs Key Players in India
10.3 India Antibody Drugs Market Size by Type
10.4 India Antibody Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Antibody Drugs Market Size (2014-2019)
11.2 Antibody Drugs Key Players in Central & South America
11.3 Central & South America Antibody Drugs Market Size by Type
11.4 Central & South America Antibody Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Antibody Drugs Introduction
12.1.4 Novartis Revenue in Antibody Drugs Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Antibody Drugs Introduction
12.2.4 Amgen Revenue in Antibody Drugs Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Antibody Drugs Introduction
12.3.4 Bristol-Myers Squibb Revenue in Antibody Drugs Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Antibody Drugs Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Antibody Drugs Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Antibody Drugs Introduction
12.5.4 Johnson & Johnson Revenue in Antibody Drugs Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 AbbVie
12.6.1 AbbVie Company Details
12.6.2 Company Description and Business Overview
12.6.3 Antibody Drugs Introduction
12.6.4 AbbVie Revenue in Antibody Drugs Business (2014-2019)
12.6.5 AbbVie Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Antibody Drugs Introduction
12.7.4 Eli Lilly Revenue in Antibody Drugs Business (2014-2019)
12.7.5 Eli Lilly Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details